HCV 阳性与非肝炎相关肝细胞癌根治性切除术后的长期结局: 一项国际多机构分析。
切换为英文Abstract:
背景: 定义非肝炎相关肝细胞癌 (non-Hep-HCC) 与丙型肝炎相关肝细胞癌 (HCV-HCC) 患者长期生存的时间顺序变化在过去的二十年里。 方法: 从国际多机构数据库中确定了 2017 和 2000年接受根治性意向切除术的 HCC 患者。分析和比较非 Hep-HCC 与 HCV-HCC 患者的总体 (OS) 和无复发生存率 (RFS)。利用倾向评分匹配 (PSM) 减轻残余偏倚。 结果: 在 617 例患者中,196 例 (31.8%) 患者为 HCV-HCC,而 421 例 (68.2%) 患者为非 Hep-HCC。而 HCV-HCC 患者随着时间的推移 OS 有所改善 (5 年 OS,2000-2009 55% vs. 2010-2017 67%,p = 0.034),非 Hep-HCC 患者的 OS 保持不变 (5 年 OS,2000-2009 53% vs. 2010-2017 52%,p = 0.905)。在匹配的队列中,HCV-HCC 患者的 OS 比非 Hep-HCC 患者的 OS 更差,2000年和 2009 (5 年 OS,12% vs. 63%,p = 0.029),但 2010年 2017年的 OS 显著优于非肝癌患者 (5 年 OS,86% vs. 73%,p = 0.035)。复发时间,模式和再治疗在非 Hep-HCC 和 HCV-HCC 患者中具有可比性。 结论: 虽然 HCV-HCC 患者的 OS 随着时间的推移而改善,但非 Hep-HCC 患者的长期生存率保持不变,更不利。
展开更多
HPB
HPB
最新影响因子:3.842 | 期刊ISSN:1365-182X | CiteScore:2.87 |
出版周期: | 是否OA:YES | 出版年份:0 |
期刊官方网址:https://www.elsevier.com/journals/hpb/1365-182X?generatepdf=true
自引率:9.40% | 研究方向:GASTROENTEROLOGY & HEPATOLOGY-SURGERY |
出版地区:ENGLAND |
SCI期刊coverage:Science Citation Index Expanded(科学引文索引扩展)
专业编辑在线一对一答疑及时解决您的问题
HPB 期刊简介
英文简介:
HPB is an international forum for clinical, scientific and educational communication. Twelve issues a year bring the reader leading articles, expert reviews, original articles, images, editorials, and reader correspondence encompassing all aspects of benign and malignant hepatobiliary disease and its management. HPB features relevant aspects of clinical and translational research and practice. Specific areas of interest include HPB diseases encountered globally by clinical practitioners in this specialist field of gastrointestinal surgery. The journal addresses the challenges faced in the management of cancer involving the liver, biliary system and pancreas. While surgical oncology represents a large part of HPB practice, submission of manuscripts relating to liver and pancreas transplantation, the treatment of benign conditions such as acute and chronic pancreatitis, and those relating to hepatobiliary infection and inflammation are also welcomed. There will be a focus on developing a multidisciplinary approach to diagnosis and treatment with endoscopic and laparoscopic approaches, radiological interventions and surgical techniques being strongly represented. HPB welcomes submission of manuscripts in all these areas and in scientific focused research that has clear clinical relevance to HPB surgical practice. HPB aims to help its readers - surgeons, physicians, radiologists and basic scientists - to develop their knowledge and practice. HPB will be of interest to specialists involved in the management of hepatobiliary and pancreatic disease however will also inform those working in related fields. Abstracted and Indexed in: MEDLINE® EMBASE PubMed Science Citation Index Expanded Academic Search (EBSCO) HPB is owned by the International Hepato-Pancreato-Biliary Association (IHPBA) and is also the official Journal of the American Hepato-Pancreato-Biliary Association (AHPBA), the Asian-Pacific Hepato Pancreatic Biliary Association (A-PHPBA) and the European-African Hepato-Pancreatic Biliary Association (E-AHPBA). Specific areas of interest include HPB diseases encountered globally by clinical practitioners in this specialist field of gastrointestinal surgery. The journal addresses the challenges faced in the management of cancer involving the liver, biliary system and pancreas. While surgical oncology represents a large part of HPB practice, submission of manuscripts relating to liver and pancreas transplantation, the treatment of benign conditions such as acute and chronic pancreatitis, and those relating to hepatobiliary infection and inflammation are also welcomed. There will be a focus on developing a multidisciplinary approach to diagnosis and treatment with endoscopic and laparoscopic approaches, radiological interventions and surgical techniques being strongly represented. HPB welcomes submission of manuscripts in all these areas and in scientific focused research that has clear clinical relevance to HPB surgical practice. HPB aims to help its readers - surgeons, physicians, radiologists and basic scientists - to develop their knowledge and practice. HPB will be of interest to specialists involved in the management of hepatobiliary and pancreatic disease however will also inform those working in related fields.
中文简介:(来自Google、百度翻译)
HPB是一个国际性的临床、科学和教育交流论坛。 每年有十二期,包括良性和恶性肝胆疾病及其治疗的所有方面的读者导论、专家评论、原始文章、图片、社论和读者通信。HPB具有临床和转化研究和实践的相关方面。 感兴趣的特定领域包括临床从业者在全球胃肠外科专业领域遇到的HPB疾病。该杂志阐述了在涉及肝脏、胆道系统和胰腺的癌症治疗中所面临的挑战。虽然外科肿瘤学是HPB实践的重要组成部分,但也欢迎提交有关肝和胰腺移植的手稿、治疗诸如急性和慢性胰腺炎等良性疾病以及与肝胆感染和炎症有关的手稿。将重点发展一个多学科的方法来诊断和治疗内镜和腹腔镜的方法,放射干预和外科技术是强有力的代表。HPB欢迎在所有这些领域和以科学为中心的研究中提交手稿,这些研究与HPB外科实践具有明显的临床相关性。 HPB旨在帮助读者——外科医生、医生、放射科医生和基础科学家——发展他们的知识和实践。参与肝胆胰疾病管理的专家将对HPB感兴趣,但也将通知相关领域的工作人员。 摘要和索引信息: MEDLINE® 埃博斯 PubMed 科学引文索引扩展 学术搜索(EBSCO) HPB由国际肝胆胰协会(IHPBA)所有,也是美国肝胆胰协会(AHPBA)、亚太肝胆胰协会(A-PHPBA)和欧洲-非洲肝胆胰协会(E-AHPBA)的官方刊物。
HPB 期刊中科院评价数据
最新中科院分区
大类(学科) | 小类(学科) | 学科排名 |
医学 |
GASTROENTEROLOGY & HEPATOLOGY (胃肠肝病学) 3区 SURGERY (外科) 2区 |
40/80 40/200 |
最新公布的期刊年发文量
年度总发文量 | 年度论文发表量 | 年度综述发表量 |
141 | 119 | 22 |
影响因子趋势图
HPB 期刊CiteScore评价数据
最新CiteScore值
引文计数(2018)
文献(2015-2017)
1370次引用
478篇文献
CiteScore排名
序号 | 类别 | 排名 | 百分位 |
1 |
大类(学科):Medicine
小类(学科):Hepatology
|
#18/59
点击查看排名表
|
|
2 |
大类(学科):Medicine
小类(学科):Gastroenterology
|
#27/128
点击查看排名表
|
|
CiteScore趋势图
Scopus涵盖范围
HPB 期刊常见问题
热门常见问题
权益保障
-
刊物信息可查
推荐刊物均可到国家新闻出
版总署网站查询正刊 -
严格保密协协议
可签署保密协议 ,不透露任
何用户信息可跟踪进程,全程
协议 -
售后服务保障
1对1服务,7x24小时在线
-
企业信誉保障
15年经验沉淀,实体公司
运营
-
偏重的研究方向:暂无
-
投稿录用比例:暂无
-
审稿速度:平均6个月的审稿周期(非官方数据)
最新评论(不代表本站观点)
-
liting7111
审稿时间: 6个月内 接受率: 比较困难(25%命中)
肝胆外科方面很不错的杂志。2020-06-06
相关期刊
-
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING...
影响因子:1.714
ISSN:1386-2073
研究方向:化学-生化研究方法
-
Neurotherapeutics...
影响因子:6.088
ISSN:1933-7213
研究方向:医学-神经科学
-
CLINICAL NEUROPHARMACOLOGY...
影响因子:1.379
ISSN:0362-5664
研究方向:医学-临床神经学
-
Expert Review of Neurotherapeutics...
影响因子:4.287
ISSN:1473-7175
研究方向:CLINICAL NEUROLOGY-PHARMACOLOGY & PHARMACY
-
HIV CLINICAL TRIALS...
影响因子:1.821
ISSN:1528-4336
研究方向:医学-传染病学
-
JOURNAL OF CHEMOTHERAPY...
影响因子:2.385
ISSN:1120-009X
研究方向:医学-药学
-
Microbial Drug Resistance...
影响因子:2.706
ISSN:1076-6294
研究方向:医学-传染病学
-
Infection and Drug Resistance...
影响因子:4.177
ISSN:1178-6973
研究方向:-
-
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY...
影响因子:5.758
ISSN:0305-7453
研究方向:医学-传染病学
HPB 投稿经验
(由下方点评分析获得,1人参与,11513人阅读)